prednisolone has been researched along with Cognition Disorders in 22 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scalp necrosis is an important sign that should prompt those approached by these patients to consider GCA." | 1.42 | Forehead necrosis, one of the many facades of giant cell arteritis. ( Palmer, VE; Vusirikala, B; Young-Zvandasara, T, 2015) |
| "Psychiatric disorders were classified according to ACR criteria for neuropsychiatric systemic lupus erythematosus (NPSLE)." | 1.37 | Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. ( Bogaczewicz, J; Hawro, T; Krupińska-Kun, M; Rabe-Jabłońska, J; Robak, E; Sysa-Jędrzejowska, A; Woźniacka, A, 2011) |
| "Susac's syndrome is a rare disease characterized by encephalopathy, retinal artery occlusion, and a sensorineural hearing loss." | 1.33 | [Susac's syndrome. A rare microangiopathy of cochlea, retina, and brain]. ( Harrèus, U; Hilgert, E; Kramer, MF; Matthias, C, 2006) |
| "We made a diagnosis of Hashimoto's encephalopathy and treated the patient with high-dose corticosteroids." | 1.32 | [A patient with Hashimoto's encephalopathy showing subacute global cognitive dysfunction]. ( Hatano, Y; Kakusaka, K; Kitada, T; Mizuno, Y; Mori, H; Urabe, T, 2003) |
| "Patients with non-communicating hydrocephalus received ventriculo-peritoneal shunts shortly after admission while communicating hydrocephalus was treated with oral acetazolamide (100 mg/kg/day) and furosemide (1 mg/kg/day) in 3-4 divided doses." | 1.31 | Long-term follow up of childhood tuberculous meningitis. ( Burger, M; Donald, P; Fertig, G; Schoeman, J; Springer, P; van Rensburg, AJ; van Zyl, F; Wait, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishihara, K | 1 |
| Naitoh, Y | 1 |
| Fukui, Y | 1 |
| Asahi, T | 1 |
| Prasad, R | 1 |
| Mishra, OP | 1 |
| Upadhyay, SK | 1 |
| Singh, TB | 1 |
| Singh, UK | 1 |
| Markakis, I | 1 |
| Alexopoulos, H | 1 |
| Poulopoulou, C | 1 |
| Akrivou, S | 1 |
| Papathanasiou, A | 1 |
| Katsiva, V | 1 |
| Lyrakos, G | 1 |
| Gekas, G | 1 |
| Dalakas, MC | 1 |
| Palmer, VE | 1 |
| Young-Zvandasara, T | 1 |
| Vusirikala, B | 1 |
| van den Munckhof, B | 1 |
| de Vries, EE | 1 |
| Braun, KP | 1 |
| Boss, HM | 1 |
| Willemsen, MA | 1 |
| van Royen-Kerkhof, A | 1 |
| de Jager, W | 1 |
| Jansen, FE | 1 |
| Fukuda, K | 1 |
| Ishida, S | 1 |
| Sakane, S | 1 |
| Furukawa, K | 1 |
| Sugino, M | 1 |
| Wong, SH | 1 |
| Saunders, MD | 1 |
| Larner, AJ | 1 |
| Das, K | 1 |
| Hart, IK | 1 |
| Hawro, T | 1 |
| Krupińska-Kun, M | 1 |
| Rabe-Jabłońska, J | 1 |
| Sysa-Jędrzejowska, A | 1 |
| Robak, E | 1 |
| Bogaczewicz, J | 1 |
| Woźniacka, A | 1 |
| Uzawa, A | 1 |
| Mori, M | 1 |
| Takahashi, Y | 1 |
| Ogawa, Y | 1 |
| Uchiyama, T | 1 |
| Kuwabara, S | 1 |
| Roberts, R | 1 |
| MacDougall, NJ | 1 |
| O'Brien, P | 1 |
| Abdelaziz, K | 1 |
| Christie, J | 1 |
| Swingler, R | 1 |
| Krastinova, E | 1 |
| Vigneron, M | 1 |
| Le Bras, P | 1 |
| Gasnault, J | 1 |
| Goujard, C | 1 |
| Schoeman, J | 1 |
| Wait, J | 1 |
| Burger, M | 1 |
| van Zyl, F | 1 |
| Fertig, G | 1 |
| van Rensburg, AJ | 1 |
| Springer, P | 1 |
| Donald, P | 1 |
| Hatano, Y | 1 |
| Mori, H | 1 |
| Kakusaka, K | 1 |
| Kitada, T | 1 |
| Urabe, T | 1 |
| Mizuno, Y | 1 |
| Warren, JD | 1 |
| Hu, MTM | 1 |
| Galloway, M | 1 |
| Greenwood, RJ | 1 |
| Rossor, MN | 1 |
| Hilgert, E | 1 |
| Harrèus, U | 1 |
| Kramer, MF | 1 |
| Matthias, C | 1 |
| Emori, A | 1 |
| Matsushima, E | 1 |
| Aihara, O | 1 |
| Ohta, K | 1 |
| Koike, R | 1 |
| Miyasaka, N | 1 |
| Kato, M | 1 |
| Krappmann, P | 1 |
| Paulides, M | 1 |
| Stöhr, W | 1 |
| Ittner, E | 1 |
| Plattig, B | 1 |
| Nickel, P | 1 |
| Lackner, H | 1 |
| Schrappe, M | 1 |
| Janka, G | 1 |
| Beck, JD | 1 |
| Langer, T | 1 |
| Johnson, H | 1 |
| Bouman, W | 1 |
| Pinner, G | 1 |
| Granel, B | 1 |
| Gaudy, C | 1 |
| Serratrice, J | 1 |
| de Roux-Serratrice, C | 1 |
| Félician, O | 1 |
| Swiader, L | 1 |
| Pache, X | 1 |
| Ceccaldi, M | 1 |
| Balzamo, M | 1 |
| Donnet, A | 1 |
| Manera, L | 1 |
| Raybaud, C | 1 |
| Disdier, P | 1 |
| Weiller, PJ | 1 |
| Mullenix, PJ | 1 |
| Kernan, WJ | 1 |
| Tassinari, MS | 1 |
| Schunior, A | 1 |
| Waber, DP | 1 |
| Howes, A | 1 |
| Tarbell, NJ | 1 |
| Haraoka, H | 1 |
| Sato, H | 1 |
| Kouda, S | 1 |
| Mitsuwa, M | 1 |
| Agatsuma, K | 1 |
| Shinoura, A | 1 |
| Bugiani, O | 1 |
| Balestreri, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Double-blind Placebo-controlled Trial of Memantine Hydrochloride for the Treatment of Childhood-onset Epileptic Encephalopathies[NCT03779672] | Phase 4 | 30 participants (Actual) | Interventional | 2019-02-07 | Completed | ||
| The Efficacy of Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE): a Randomized Control Trial[NCT04305418] | 26 participants (Actual) | Interventional | 2017-01-23 | Completed | |||
| The Efficacy of Mindfulness- Based Intervention for Fibromyalgia Patients: a Randomized Control Trial[NCT04304664] | 95 participants (Actual) | Interventional | 2017-01-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Cognition Disorders
| Article | Year |
|---|---|
Psychiatric aspects of temporal arteritis: a case report and review of the literature.
Topics: Aged; Biopsy; Blood Sedimentation; Cognition Disorders; Diagnosis, Differential; Female; Geriatric A | 1997 |
2 trials available for prednisolone and Cognition Disorders
| Article | Year |
|---|---|
An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis.
Topics: Aged; Anti-Inflammatory Agents; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Immu | 2010 |
Cognitive dysfunction in systemic lupus erythematosus.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema | 2005 |
Cognitive dysfunction in systemic lupus erythematosus.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema | 2005 |
Cognitive dysfunction in systemic lupus erythematosus.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema | 2005 |
Cognitive dysfunction in systemic lupus erythematosus.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Cognition Disorders; Fema | 2005 |
19 other studies available for prednisolone and Cognition Disorders
| Article | Year |
|---|---|
[A case of Hashimoto's encephalopathy showing improvement in higher brain functions after a low-dose steroid therapy].
Topics: Administration, Oral; Aged, 80 and over; Brain; Cognition Disorders; Electroencephalography; Encepha | 2019 |
Cognitive and behaviour dysfunction of children with neurocysticercosis: a cross-sectional study.
Topics: Anticonvulsants; Case-Control Studies; Child; Child, Preschool; Cognition; Cognition Disorders; Cros | 2014 |
Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.
Topics: Antibodies; Aspartic Acid; Choline; Cognition Disorders; Creatine; Female; Glutamate Decarboxylase; | 2014 |
Forehead necrosis, one of the many facades of giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blindness; Cognition Disorders; Female; Forehead; | 2015 |
Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.
Topics: Adolescent; Case-Control Studies; Chemokine CCL2; Chemokine CCL3; Child; Child, Preschool; Cognition | 2016 |
[Brain MRI of reversible, recurrent white matter lesions in a patient with a 35-year history of neuro-Behçet disease].
Topics: Aged; Behcet Syndrome; Brain; Cognition Disorders; Disease Progression; Female; Glucocorticoids; Hum | 2009 |
Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration.
Topics: Adult; Aged; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Humans; Lupus Eryt | 2011 |
Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Brain; Cognition Disorders; Female; Humans; Limbic | 2012 |
Not hysteria: ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Cognition Disorders; Dermoid | 2012 |
Treatment of limbic encephalitis with anti-glioma-inactivated 1 (LGI1) antibodies.
Topics: Aged; Anti-Inflammatory Agents; Antibodies; Brain Neoplasms; Cognition Disorders; Electroencephalogr | 2012 |
Long-term follow up of childhood tuberculous meningitis.
Topics: Acetazolamide; Anti-Inflammatory Agents; Antitubercular Agents; Brain; Child; Cognition Disorders; D | 2002 |
[A patient with Hashimoto's encephalopathy showing subacute global cognitive dysfunction].
Topics: Aged; Brain Diseases; Cognition Disorders; Diagnosis, Differential; Female; Humans; Prednisolone; Th | 2003 |
Observations on the human rejection behaviour syndrome: Denny-Brown revisited.
Topics: Anti-Inflammatory Agents; Atrophy; Brain; Cognition Disorders; Drug Therapy, Combination; Humans; Li | 2004 |
[Susac's syndrome. A rare microangiopathy of cochlea, retina, and brain].
Topics: Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Brain Stem; Cerebrovascular Disorders; Cochl | 2006 |
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implicat
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2007 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Femal | 2001 |
An animal model to study toxicity of central nervous system therapy for childhood acute lymphoblastic leukemia: effects on behavior.
Topics: Animals; Behavior, Animal; Brain; Cognition Disorders; Combined Modality Therapy; Female; Humans; Ma | 1990 |
[A case of hypereosinophilic syndrome associated with consciousness disorder and hemiparesis].
Topics: Aged; Cognition Disorders; Consciousness Disorders; Eosinophilia; Hemiplegia; Humans; Male; Predniso | 1990 |
Addison-Schilder's disease. Report of a case with probable relapsing addisonian encephalopathy.
Topics: 17-Ketosteroids; Addison Disease; Adolescent; Adrenal Glands; Brain; Cognition Disorders; Demyelinat | 1971 |